An enzyme-linked immunosorbent assay (ELISA) for detection of immunoglobulin G (IgG) and IgM to cardiolipin, lecithin, and cholesterol (VDRL [Venereal Disease Research Laboratory] ELISA) is described. The specificity of the VDRL ELISA for IgG and IgM was 99.6 and 99.5%, respectively, with sera from 1,008 persons without syphilis. For a group of patients with false-positive results in traditional nontreponemal tests and for patients with autoimmune diseases, the VDRL ELISA for IgG had a higher specificity than the VDRL ELISA for IgM. The sensitivity for IgG and IgM with 118 sera from patients with untreated syphilis was 96.6 and 94.9%, respectively, which was equivalent to the sensitivities of the traditional nontreponemal tests. The performance of the VDRL ELISA was compared with that of an ELISA that uses cardiolipin as the antigen (cardiolipin ELISA). The VDRL ELISA was significantly more sensitive (P s 0.01) than the cardiolipin ELISA with 25 sera from syphilis patients but was less sensitive (P -0.01) with 53 sera from patients with autoimmune diseases. The antibody reactivity in the VDRL ELISA could not be absorbed out by lecithin and cholesterol, and the sera from patients with syphilis did not react in an ELISA that uses cholesterol and lecithin as the antigen. This indicates that cholesterol and lecithin, although not antigenic by themselves, may change the structural form of the epitope on cardiolipin so that it becomes more recognizable for antibodies in syphilis and less recognizable for antibodies in autoimmune diseases. The results of the VDRL ELISA were expressed in percentages of the absorbance value of a positive control. The VDRL ELISA gave, without titration of sera, quantitative results that correlated with the quantitative results of the traditional nontreponemal tests obtained by titration. The VDRL ELISA will be well suited for large-scale testing for syphilis and may replace other nontreponemal tests.
Serological tests for syphilis can be divided in two major groups, the nontreponemal and the treponemal tests. The nontreponemal tests or standard tests for syphilis detect antibodies against the phospholipid hapten cardiolipin, in complex with lecithin and cholesterol. This antigen complex is used either in a complement fixation test (Wassermann test) or in agglutination tests such as the Venereal Disease Research Laboratory (VDRL) test, the automated reagin test (ART), or the rapid plasma reagin test (19) . The serological diagnosis of syphilis still depends to a large extent on the results of a nontreponemal test, supplemented when necessary by a confirmatory treponemal antibody test, i.e., the fluorescent treponemal antibody absorption (FTA-ABS) test (19) or the Treponema pallidum hemagglutination test (13) . The nontreponemal tests are extremely valuable for screening purposes and may have even higher specificities for syphilis than the treponemal tests (10, 15) . The treponemal tests should not be used as screening tests, but only as confirmatory tests on highly selected serum samples from patients who are suspected of a present or previous treponemal infection (3, 15) . Furthermore, whereas a nontreponemal test generally becomes negative within 6 to 12 months after treatment of early syphilis, the treponemal tests may remain positive for many years (2, 16) . Quantitative nontreponemal tests are therefore useful both for * Corresponding author. posttreatment monitoring and for the detection of reinfections (10) .
The nontreponemal tests presently used are not ideal. None of the tests used today is able to distinguish between immunoglobulin G (IgG) and IgM without previous separation of serum. Detection of IgM is important for the diagnosis of congenital syphilis, because IgM does not cross the intact placenta, and IgM in newborns indicates active syphilis. The Wassermann test used in Europe requires fresh complement, which makes the test troublesome. The VDRL test requires fresh and accurate preparation of antigen and microscopic visualization of agglutination. The ART and the rapid plasma reagin test are easier to perform, but interpretation of weak-positive results may often be difficult. Falsenegative results may occur in the VDRL test, the ART, and the rapid plasma reagin test when strongly positive sera are tested, because of prozone phenomena (18) . Recently a radioimmunosorbent assay (7) and an enzyme-linked immunosorbent assay (ELISA) (11) 
MATERIALS AND METHODS
Lipid antigens. Cardiolipin was purified by the method of Pangborn (12) , and lecithin was purified by the method of Riis Nielsen (14) . Cholesterol was obtained from Pfanstiehl Lab, Waukegan, 111. The purity of all lipids was tested by thin-layer chromatography.
Conjugates. The conjugates used were horseradish peroxidase-conjugated rabbit anti-human IgG (code P214, lot 091) and anti-human IgM (code P215, lot 0.25A), both from DAKO-Immunoglobulins, Copenhagen Routine syphilis serological methods. All sera were tested by the ART (19) and, if positive, quantified by the rapid plasma reagin test (19) . All sera were also tested by the CWRM test as modified by Môrch (17) , and sera from syphilis patients were also analyzed by the FTA-ABS test. The conjugate used in the FTA-ABS test was a rabbit antihuman IgG, IgA, IgM (code F1009; DAKO-Immunoglobulins).
Diagnoses of syphilis. The diagnoses of syphilis were made on the basis of extensive centralized, serological, and clinical data collected at the Department of Treponematoses, Statens Seruminstitut, Copenhagen.
Sera. Sera were chosen from specimens submitted for routine syphilis serological analysis during a 4-month period in 1986, except for 25 samples from patients with secondary syphilis (group 2), which were collected in 1980 and stored at -20°C, and 500 samples from blood donors, which were collected in 1982. None of the sera tested was heat inactivated.
Group 1: patients with untreated primary syphilis. There were 46 patients with primary untreated syphilis. All patients had lesions suspected ofbeing chancres, and all had sera that were reactive in the FTA-ABS test.
Group 2: patients with untreated secondary syphilis. There were 32 patients with untreated secondary syphilis. All patients had exanthema, and all gave sera that were reactive in the CWRM, ART, and FTA-ABS tests.
Group 3: patients with untreated late syphilis. There were five patients with untreated neurosyphilis. All patients had cerebrospinal fluid that gave reactive results in the CWRM and FTA-ABS tests.
Group 4: patients with untreated serologically diagnosed early syphilis. There were 35 patients with serologically diagnosed syphilis. All patients were positive in the CWRM, ART, and FTA-ABS tests. None of the patients had clinical findings indicating syphilis, and because of a rapid serological response to treatment the diagnosis of early syphilis was made.
Group 5: patients with treated syphilis. There were 146 patients with treated syphilis. The stages at the time of diagnosis differed, and both early and late syphilis cases were represented. Six patients were CWRM positive and ART negative. A total of 31 patients were CWRM negative and ART positive, 91 patients were both CWRM and ART positive, and 24 patients were negative in both tests. All sera were reactive in the FTA-ABS test.
Group 6: persons whose sera gave false-positive results. There were 86 patients with no history or signs of syphilis whose sera gave positive results in either the CWRM test or the ART and negative results in the FTA-ABS test. Repeated tests of sera from these persons confirmed that the reactivity in the previous samples was not caused by technical errors or syphilis. Of the patients, 57 had sera that were positive in the CWRM test and negative in the ART, 24 had sera that were negative in the CWRM test and positive in the ART, and 5 had sera that were positive in both the CWRM test and the ART.
Group 7: persons without syphilis (blood donors). There were 500 sera from unpaid voluntary blood donors without syphilis. All sera were nonreactive in the CWRM test and the ART, and none of the persons in this group had a history of past or present syphilis.
Group 8: patients without syphilis. There were 508 sera from 343 patients from venereal disease clinics, 85 hospital A total of 508 sera (group 8) submitted from venereal disease clinics, hospital departments, and general practitioners for syphilis serology were tested in the VDRL ELISA. None of the sera came from patients with past or present histories of syphilis. All sera were found negative in the CWRM test and the ART. Three sera were reactive in the VDRL ELISA for IgG with values of 24, 27, and 33. Another two sera were found positive in the VDRL ELISA for IgM, both having the value of 34. None of these five sera was reactive in the FTA-ABS test. The specificity of the VDRL ELISA for IgG was therefore 99.4%, and the specificity of the VDRL ELISA for IgM was 99.6% (Table 1) .
We also tested 30 sera containing rheumatoid factors (group 9). One of these sera was strongly reactive in the CWRM test, and none was reactive in the ART. None of these was reactive in the VDRL ELISA for IgG but three were reactive in the VDRL ELISA for IgM with values of 37, 42, and 44. One of the IgM-positive sera was the one reactive in CWRM.
The total assay precision of the VDRL ELISA was determined by assaying two negative and three positive sera in duplicates on 10 different days ( Table 2) .
The VDRL antigen is composed of cardiolipin, lecithin, and cholesterol, and to study the specificity of the VDRL ELISA we absorbed four sera from syphilis patients either with complete VDRL antigen or with cholesterol-lecithin before testing. Only the complete VDRL antigen was able to block the ELISA reactivity (Table 3) . Furthermore, microtiter plates coated with cholesterol-lecithin were not able to bind either IgG or IgM in sera from controls or syphilis patients (data not shown). (Table 4 ). The VDRL ELISA for both IgG and IgM was more sensitive with a group of sera from patients with secondary syphilis than the cardiolipin ELISA (P -0.01). On the other hand, the cardiolipin ELISA for both IgG and IgM was more sensitive than the VDRL ELISA for IgG (P < 0.05) and IgM (P < 0.01) with sera from patients with SLE. The cardiolipin ELISA was also more sensitive than the VDRL ELISA with the whole group of sera from patients with the different autoimmune diseases (P -0.01).
Comparison of the VDRL ELISA with the CWRM test and the ART. The results of the syphilis serological tests are shown in Table 1 . A total of 270 sera from syphilis patients was tested. Of the sera from patients with untreated primary syphilis (group 1), 43 (93.5%) were reactive in the VDRL ELISA for IgG and 40 (87.0%) were reactive for IgM. None of the sera was reactive only for IgM, and the combined use of VDRL ELISA for IgG and IgM compared with the use of the VDRL ELISA for IgG alone did not increase the sensitivity. The differences in sensitivity of the nontreponemal serological tests with sera from patients with primary syphilis were not statistically significant. For untreated secondary syphilis (group 2) and untreated late syphilis (group 3), all tests had a sensitivity of 100%. In the group of patients with serologically diagnosed untreated early syphilis (group 4), the patients were selected on the basis of positive CWRM, ART, and FTA-ABS test results. All of these sera were reactive in the VDRL ELISA for IgM, and all but one were positive in the VDRL ELISA for IgG.
The distribution of the ELISA values determined by the VDRL ELISA for IgG is shown in Fig. 1 . The ELISA values in syphilis range widely, from the cutoff of 20 to as high as 210. The quantitative results of VDRL ELISA for both IgG and IgM showed an excellent correlation with the quantitative results of both the CWRM test and the ART ( Fig. 2 ; Table 5 ).
In the group of patients with treated syphilis whose sera were positive in both the CWRM test and the ART (group 5c), the VDRL ELISA for IgG antibodies had a higher sensitivity than the ELISA for IgM antibodies (P < 0.01). The differences in sensitivity between the ELISA for IgG and the CWRM test and the ART were not significant.
In the group of 57 patients with false-positive CWRM results (group 6a), the VDRL ELISA for IgG had a higher specificity than the VDRL ELISA for IgM (P < 0.05). Only four (7%) of the sera in this group were positive for both IgG and IgM antibodies in the VDRL ELISA. Also, in the group of 24 patients with false-positive ART results (group 6b), the specificity of the VDRL ELISA for IgG was higher than that for IgM (P < 0.05). All patients with IgG in this group had IgM. Fig.  2 ). The discrimination between positive and negative results was good in the VDRL ELISA for both IgG and IgM. The ratio between the median ELISA values obtained with sera from patients with untreated syphilis and sera from controls was 25 (positive-negative ratio).
DISCUSSION
The performance of the VDRL ELISA was compared with that of an ELISA that uses cardiolipin as the antigen. Anti-cardiolipin antibodies have proved to be significantly associated with the lupus anticoagulant, thrombocytopenia, spontaneous abortions, and thrombosis in SLE patients (4, 6-9, 11, 21) . The cardiolipin ELISA is now used in several laboratories to define this high risk subset of SLE patients. Although the cardiolipin ELISA from a theoretical point of view would be ideal as a syphilis serological method, it has not been used as such.
The results of the present study show that the VDRL ELISA was significantly more sensitive than a cardiolipin ELISA with sera from syphilis patients (Table 4) . On the contrary, the cardiolipin ELISA was more sensitive than the VDRL ELISA with sera from patients with autoimmune diseases. We showed that the antibody reactivity in the VDRL ELISA could not be absorbed out by lecithin and cholesterol (Table 3) , and sera from patients with syphilis did not react in an ELISA that uses cholesterol and lecithin as the antigen. This indicates that cholesterol and lecithin, although not antigenic by themselves, may change the structural form of the epitope on cardiolipin, so that it becomes more recognizable for antibodies in syphilis and less recognizable for antibodies in SLE. Costello and Green (5), using a different assay principle, also found that lecithin, although not antigenic, increased the sensitivity of cardiolipin with regard to detection of antibodies in syphilis. Koike et al. (11) and Colaco and Male (4) did not find any correlation between anti-VDRL antibody titer and anti-cardiolipin antibody titer in patients with SLE. Colaco and Male (4) also demonstrated significantly different profiles of reactivity with syphilitic sera and SLE sera against different phospholipid antigens. These results indicate that antibodies in syphilis and SLE are directed against different but cross-reactive phospholipid epitopes and are consistent with our findings.
The VDRL ELISA may substitute traditional nontreponemal tests, especially in laboratories using the ELISA principle for other tests. The VDRL ELISA is especially useful for large-scale testing, i.e., in laboratories undertaking blood donor, prenatal, and premarital screening for syphilis, and it would also be useful in laboratories receiving a large number of samples from venereal disease clinics. The VDRL ELISA has other advantages. It dilution of serum, and the use of an automatic plate reader eliminates the subjectivity of visual reading.
